DK1095059T3 - Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse - Google Patents

Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse

Info

Publication number
DK1095059T3
DK1095059T3 DK99933284T DK99933284T DK1095059T3 DK 1095059 T3 DK1095059 T3 DK 1095059T3 DK 99933284 T DK99933284 T DK 99933284T DK 99933284 T DK99933284 T DK 99933284T DK 1095059 T3 DK1095059 T3 DK 1095059T3
Authority
DK
Denmark
Prior art keywords
chips
staphylococcus
chemotaxia
inhibitory protein
treatment
Prior art date
Application number
DK99933284T
Other languages
Danish (da)
English (en)
Inventor
Strijp Johannes Antonius G Van
Kessel Cornelis Petrus Mar Van
Original Assignee
Alligator Bioscience Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alligator Bioscience Ab Publ filed Critical Alligator Bioscience Ab Publ
Application granted granted Critical
Publication of DK1095059T3 publication Critical patent/DK1095059T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99933284T 1998-07-10 1999-07-12 Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse DK1095059T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1009614 1998-07-10

Publications (1)

Publication Number Publication Date
DK1095059T3 true DK1095059T3 (da) 2006-10-02

Family

ID=19767471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99933284T DK1095059T3 (da) 1998-07-10 1999-07-12 Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse

Country Status (22)

Country Link
US (2) US20050143307A1 (no)
EP (1) EP1095059B1 (no)
JP (1) JP2002520336A (no)
KR (1) KR20010053290A (no)
CN (1) CN1309662A (no)
AT (1) ATE328898T1 (no)
AU (1) AU4935999A (no)
BG (1) BG105120A (no)
BR (1) BR9911944A (no)
CA (1) CA2333898A1 (no)
CY (1) CY1105343T1 (no)
DE (1) DE69931784T2 (no)
DK (1) DK1095059T3 (no)
ES (1) ES2270609T3 (no)
HU (1) HUP0102975A2 (no)
IL (1) IL140768A0 (no)
NO (1) NO20010140L (no)
NZ (1) NZ509051A (no)
PL (1) PL345452A1 (no)
PT (1) PT1095059E (no)
WO (1) WO2000002913A1 (no)
ZA (1) ZA200100092B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL345452A1 (en) * 1998-07-10 2001-12-17 Jari Pharmaceuticals Bv Chemotaxis-inhibiting protein of staphylococcus
EP1118663A1 (en) * 2000-01-07 2001-07-25 Universiteit Utrecht Nucleic acids encoding chemotaxis inhibitory polypeptides
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
WO2003006048A1 (en) * 2001-07-11 2003-01-23 Jari Pharmaceuticals B.V. Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
DK1641926T3 (da) * 2003-07-08 2011-06-27 Umc Utrecht Holding Bv Terapeutisk anvendelse af LPI, en stafylokokal lectinstiinhibitor ved inflammatoriske sygdomme
EP1586583A3 (en) * 2004-04-16 2005-11-16 Alligator Bioscience AB (publ) Compounds that block C5a complement receptor and their use in therapy
EP1778882A2 (en) 2004-07-26 2007-05-02 State of Israel, Department of Agriculture, Kimron Veterinary Institute Novel bacteria and pharmaceutically active products obtained therefrom
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0669989A1 (en) * 1991-08-22 1995-09-06 Washington University Polynucleotide probes for salmonella
US5514555A (en) * 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5514455A (en) * 1994-07-08 1996-05-07 Union Carbide Chemicals & Plastics Technology Corporation Film extruded from an in situ blend of ethylene copolymers
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
US7153655B2 (en) * 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
PL345452A1 (en) * 1998-07-10 2001-12-17 Jari Pharmaceuticals Bv Chemotaxis-inhibiting protein of staphylococcus
JP3722194B2 (ja) * 1999-05-20 2005-11-30 セイコーエプソン株式会社 画像表示システム
EP1118663A1 (en) * 2000-01-07 2001-07-25 Universiteit Utrecht Nucleic acids encoding chemotaxis inhibitory polypeptides
US6958213B2 (en) * 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) * 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
DE60312507T3 (de) * 2002-05-17 2011-08-18 Alligator Bioscience Ab Eine methode zur in vitro molekularen evolution der proteinfunktion

Also Published As

Publication number Publication date
US20050143307A1 (en) 2005-06-30
AU4935999A (en) 2000-02-01
DE69931784D1 (de) 2006-07-20
DE69931784T2 (de) 2007-06-14
BG105120A (en) 2001-11-30
US20080242605A1 (en) 2008-10-02
BR9911944A (pt) 2001-09-25
EP1095059A1 (en) 2001-05-02
NO20010140D0 (no) 2001-01-09
HUP0102975A2 (hu) 2001-11-28
ES2270609T3 (es) 2007-04-01
JP2002520336A (ja) 2002-07-09
IL140768A0 (en) 2002-02-10
WO2000002913B1 (en) 2000-03-30
CY1105343T1 (el) 2010-03-03
NZ509051A (en) 2003-01-31
NO20010140L (no) 2001-03-01
WO2000002913A1 (en) 2000-01-20
PL345452A1 (en) 2001-12-17
CA2333898A1 (en) 2000-01-20
ATE328898T1 (de) 2006-06-15
KR20010053290A (ko) 2001-06-25
ZA200100092B (en) 2001-07-23
CN1309662A (zh) 2001-08-22
PT1095059E (pt) 2006-10-31
EP1095059B1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
EA200301115A1 (ru) Кристаллические формы азитромицина
SE0102315D0 (sv) Compounds
WO2003005999A3 (en) Methods of treating cytokine mediated diseases
GB0125222D0 (en) Composition for the treatment of microbial infections
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
ATE418554T1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
TR200003170T2 (tr) MRS inhibitörleri ve bakterisid olarak kullanılan quinolone'lar
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
ATE433963T1 (de) Fab-i inhibitoren
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
ATE276262T1 (de) Oxazinochinolone für die behandlung viraler infektionen
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
AU2003210850A1 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
DK1439840T3 (da) Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase
DE60326710D1 (de) Trizyklische antibakterielle makrolidderivate
SE0002045D0 (sv) New use
DE60324466D1 (de) Zusammensetzungfür die behandlung von mycobakterieninfektionen
SE0200119D0 (sv) Novel compounds